SC Gulati
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
- Hematology 14
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 7
- Oncology 5
- Neutropenia and Cancer Infections 2
- Co-authors
- BD Clarkson (9 shared papers)Roberto M. Lemoli (7 shared papers)MA Moore (3 shared papers)A Strife (3 shared papers)Neal Flomenberg (3 shared papers)P Black (2 shared papers)Isabel Cunningham (3 shared papers)Glenn Heller (2 shared papers)
- Journals
- Blood (11 papers)PubMed (5 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
SC Gulati
16 papers receiving 383 citations
Peers
Comparison fields: 5 of 44
- Hematology 284
- Immunology 105
- Genetics 43
- Oncology 107
- Transplantation 10
Countries citing papers authored by SC Gulati
This map shows the geographic impact of SC Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SC Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SC Gulati more than expected).
Fields of papers citing papers by SC Gulati
This network shows the impact of papers produced by SC Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SC Gulati. The network helps show where SC Gulati may publish in the future.
Co-authors
The 25 scholars most cited alongside SC Gulati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 77 | |
| 2 | 1992 | 61 | |
| 3 | 1992 | 56 | |
| 4 | 1991 | 42 | |
| 5 | 1987 | 35 | |
| 6 | Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. | 1991 | 30 |
| 7 | 1993 | 23 | |
| 8 | Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. | 1994 | 20 |
| 9 | 1993 | 19 | |
| 10 | TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro. | 1992 | 15 |
| 11 | 1987 | 14 | |
| 12 | Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. | 1989 | 5 |
| 13 | 1987 | 3 | |
| 14 | 1991 | 2 | |
| 15 | Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide. | 1990 | 2 |
| 16 | 1985 | 2 |
About SC Gulati
SC Gulati is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 16 papers that have together received 406 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers), Photodynamic Therapy Research Studies (4 papers), Hematological disorders and diagnostics (3 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Neutropenia and Cancer Infections (2 papers) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Hematology (284 citations), Immunology (105 citations), Genetics (43 citations), Oncology (107 citations) and Transplantation (10 citations). SC Gulati has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include BD Clarkson, Roberto M. Lemoli, MA Moore, A Strife, Neal Flomenberg, P Black, Isabel Cunningham, Glenn Heller, Hugo Castro‐Malaspina and RJ O’Reilly. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.